Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fenglei Capital is a Chinese venture capital firm that specializes in early-to-growth stage investments within the healthcare, life sciences, and technology sectors. The firm focuses on identifying innovative companies in areas such as biotechnology, medical devices, and digital health. Fenglei Capital provides strategic support and capital to help its portfolio companies scale and achieve market leadership. It is known for its deep industry expertise and active involvement in the Chinese healthcare ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fenglei Capital.